Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DS4M1A
|
|||
| Drug Name |
SM09419
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Hematologic tumour [ICD-11: 2B33.Y] | Phase 1 | [1] | |
| Company |
Biosplice
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cdc-like kinase (CLK) | Target Info | Inhibitor | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | SM09419, a Novel, Small-Molecule CDC-like Kinase (CLK) Inhibitor, Demonstrates Strong Inhibition of the Wnt Signaling Pathway and Antitumor Effects in FMS-like Tyrosine Kinase 3 (FLT3)-Mutant Acute Myeloid Leukemia Models. Blood; 2019,134 (Supplement_1):1377. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.